Stockreport

This Biotech Stock Rocketed 15% On Rumors Biogen Could Buy It [Investor's Business Daily]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Technology Related news 3:00 AM ET Acorda Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating Biotech Stocks To Watch [Read more]